CN
CN
Our latest
Creative Biosciences
Good News | Lunsafe® Receives ANVISA Registration Approval in Brazil, Setting Sail for the Latin American Market!

On August 17, 2026, Lunsafe® — the Methylation Detection Kit for Human HOXB4 and SRCIN1 Genes (Real-Time PCR), independently developed by Creative Biosciences (Guangzhou) Co., Ltd. — was officially granted registration approval by Brazil’s National Heal

Aug 26 , 2026
Media Coverage
Authoritative media releases


Read more
Press releases
Clinical Utility of Colosafe®Is Once Again Proved Valuable！
Mar 17 , 2021
Top 100! Creative Biosciences Was Named "The First Guangzhou’s Top 100 Emerging Enterprises"
Dec 27 , 2023
CreativeBio has the greatest honor to resonate with “March Is Colorectal Cancer Awareness Month”
Mar 09 , 2021
2021 Happy Chinese New Year
Feb 01 , 2021
Happy 6th Birthday to Creative Biosciences!
Jan 14 , 2021
Science and Technology Promotes Health, Innovation Shapes Future.Successful Topping Out Ceremony for Creative Biosciences’ New Headquarter Buildings
Dec 14 , 2023
Robust Performance of Colosafe®!Multicenter Clinical Study Published on Clinical Epigenetics
Nov 01 , 2020
Blockbuster! CreativeBio Completed the Rd C Financing of ￥600 million Laying a Solid Foundation to Be the Leader in Earl
Sep 30 , 2020
Adding Soaring Wings to the Tiger-CreativeBio Welcomes its New COO and VP(Public Health)
Sep 14 , 2020
Creative Biosciences Successfully Completed the Acquisition of Helixgen
Mar 31 , 2020
A Colorectal Cancer Screening Program Has Been Officially Launched by The Ministry of Science and Technology
Sep 18 , 2021

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention